Evidence map›Paper›PMID 37923838›Full record

ArticleNature medicine2024

Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.

John M Kirkwood, Michele Del Vecchio, Jeffrey Weber, Christoph Hoeller, Jean-Jacques Grob, Peter Mohr, Carmen Loquai, Caroline Dutriaux, Vanna Chiarion-Sileni, Jacek Mackiewicz and 11 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 18 institutions in 8 countries.

John M KirkwoodUPMC Hillman Cancer Center, Pittsburgh, PA, USA. kirkwoodjm@upmc.edu.ORCID http://orcid.org/0000-0002-3570-4476
Michele Del VecchioFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Jeffrey WeberNYU Langone Medical Center, New York, NY, USA.
Christoph HoellerMedizinische Universität Wien, Vienna, Austria.ORCID http://orcid.org/0000-0003-1192-0227
Jean-Jacques GrobHôpital de la Timone, Marseille, France.
Peter MohrElbe Klinikum Buxtehude, Buxtehude, Germany.
Carmen LoquaiUniversity Medical Center Mainz, Mainz, Germany.
Caroline DutriauxHôpital Saint André, Bordeaux, France.
Vanna Chiarion-SileniIstituto Oncologico Veneto, IOV-IRCCS, Padova, Italy.
Jacek MackiewiczInstitute of Oncology, Poznan University of Medical Sciences, Poznan, Poland.
Piotr RutkowskiMaria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Petr ArenbergerCharles University Third Faculty of Medicine and University Hospital Královské Vinohrady, Prague, Czech Republic.
Gaelle QuereuxNantes University Hospital, Nantes, France.
Tarek M MeniawyUniversity of Western Australia and Sir Charles Gairdner Hospital, Perth, WA, Australia.ORCID http://orcid.org/0000-0002-1457-6137
Paolo A AsciertoIstituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy.ORCID http://orcid.org/0000-0002-8322-475X
Alexander M MenziesMelanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
Piyush DuraniBristol Myers Squibb, Princeton, NJ, USA.
Maurice LoboBristol Myers Squibb, Princeton, NJ, USA.
Federico CampigottoBristol Myers Squibb, Princeton, NJ, USA.
Brian Gastman *Cleveland Clinic, Cleveland, OH, USA.
Georgina V Long *Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-8894-3545
Bristol-Myers Squibb (United States) · USThe University of Sydney · AUCharles University · CZCleveland Clinic · USElbe Kliniken Stade-Buxtehude · DEFondazione IRCCS Istituto Nazionale dei Tumori · ITHôpital de la Timone · FRHôpital Saint-André · FRIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITIstituto Oncologico Veneto · ITJohannes Gutenberg University Mainz · DEMedical University of Vienna · ATNantes Université · FRNYU Langone Health · USPoznan University of Medical Sciences · PLThe Maria Sklodowska-Curie National Research Institute of Oncology · PLThe University of Western Australia · AUUPMC Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37923838
PMCPMC10878963
OpenAlexW4388304352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.